F 2-isoprostanes and adiposity in older adults

Obesity

Volumn 19, Issue 4, 2011, Pages 861-867

  Kanaya, Alka M ^a   Wassel, Christina L ^b   Stoddard, Pamela J ^a   Harris, Tamara B ^c   Cummings, Steven R ^d   Kritchevsky, Stephen B ^e   Goodpaster, Bret H ^f   Green, Christie ^g   Satterfield, Suzanne ^g   Gross, Myron D ^h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF PITTSBURGH   (United States)

^g UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^h UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ISOPROSTANE DERIVATIVE; LEPTIN; TUMOR NECROSIS FACTOR ALPHA; INSULIN;

AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD SAMPLING; BODY COMPOSITION; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; SEX DIFFERENCE; WEIGHT REDUCTION; ADIPOSE TISSUE; BLOOD; BODY MASS; BODY WEIGHT; METABOLISM; METHODOLOGY; PHOTON ABSORPTIOMETRY; RADIOGRAPHY;

IPS;

ABSORPTIOMETRY, PHOTON; ADIPONECTIN; ADIPOSE TISSUE; ADIPOSITY; AGED; ANALYSIS OF VARIANCE; BODY COMPOSITION; BODY MASS INDEX; BODY WEIGHT; F2-ISOPROSTANES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN; LEPTIN; MALE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79953187567     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2010.243     Document Type: Article

References (34)

1. Cracowski JL, Bonaz B, Bessard G et al. Increased urinary F2-isoprostanes in patients with Crohn's disease. Am J Gastroenterol 2002;97:99-103. (Pubitemid 34059771)
2. Basu S, Whiteman M, Mattey DL, Halliwell B. Raised levels of F(2)-isoprostanes and prostaglandin F(2α) in different rheumatic diseases. Ann Rheum Dis 2001;60:627-631 (Pubitemid 32493991)
3. Halliwell B. Antioxidants in human health and disease. Annu Rev Nutr 1996;16:33-50. (Pubitemid 26286845)
4. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999;282:2131-2135.
5. Vozarova B, Weyer C, Hanson K et al. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 2001;9:414-417 (Pubitemid 33603868)
6. Esposito K, Pontillo A, Di Palo C et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003;289:1799-1804. (Pubitemid 37430249)
7. Matsuzawa Y Nakamura T, Shimomura I, Kotani K. Visceral fat accumulation and cardiovascular disease. Obes Res 1995;3 Suppl 5:645S-647S.
8. Fujimoto WY, Bergstrom RW, Boyko EJ et al. Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study Diabetes Care 1999;22:1808-1812
9. Kanaya AM, Wassel Fyr C, Vittinghoff E et al.; Health ABC Study Serum adiponectin and coronary heart disease risk in older black and white Americans. J Clin Endocrinol Metab 2006;91:5044-5050. (Pubitemid 44917348)
10. Rösen P, Nawroth PP, King G et al. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society Diabetes Metab Res Rev 2001;17:189-212 (Pubitemid 32624602)
11. Morrow JD, Roberts LJ 2nd. The isoprostanes. Current knowledge and directions for future research. Biochem Pharmacol 1996;51:1-9
12. Kadiiska MB, Gladen BC, Baird DD et al. Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med 2005;38:698-710. (Pubitemid 40249740)
13. Davi G, Alessandrini P Mezzetti A et al. In vivo formation of 8-epi-prostaglandin F2α is increased in hypercholesterolemia. Arterioscler Thromb Vasc Biol 1997;17:3230-3235 (Pubitemid 28016082)
14. Gopaul NK, Anggård EE, Mallet AI et al. Plasma 8-epi-PGF2α levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett 1995;368:225-229.
15. Davì G, Ciabattoni G, Consoli A et al. In vivo formation of 8-iso-prostaglandin f2α and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation 1999;99:224-229. (Pubitemid 29056363)
16. Cipollone F Ciabattoni G, Patrignani P et al. Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina. Circulation 2000;102:1007-1013. (Pubitemid 30657517)
17. Block G, Dietrich M, Norkus EP et al. Factors associated with oxidative stress in human populations. Am J Epidemiol 2002;156:274-285. (Pubitemid 34810481)
18. Keaney JF Jr, Larson MG, Vasan RS et al.; Framingham Study Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study Arterioscler Thromb Vasc Biol 2003;23 434-439 (Pubitemid 36337219)
19. Urakawa H, Katsuki A, Sumida Y et al. Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab 2003;88:4673-4676. (Pubitemid 37357510)
20. Fujita K, Nishizawa H, Funahashi T, Shimomura I, Shimabukuro M. Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circ J 2006;70:1437-1442. (Pubitemid 44672900)
21. Wu B, Fukuo K, Suzuki K, Yoshino G, Kazumi T. Relationships of systemic oxidative stress to body fat distribution, adipokines and inflammatory markers in healthy middle-aged women. Endocr J 2009;56:773-782
22. Pou KM, Massaro JM, Hoffmann U et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study Circulation 2007;116:1234-1241 (Pubitemid 47517534)
23. Morrow JD, Roberts LJ 2nd. Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Meth Enzymol 1999; 300: 3-12. (Pubitemid 28500576)
24. Goodpaster BH, Carlson CL, Visser M et al. Attenuation of skeletal muscle and strength in the elderly: the Health ABC Study J Appl Physiol 2001;90:2157-2165 (Pubitemid 32467407)
25. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419. (Pubitemid 15018832)
26. Weigle DS. Leptin and other secretory products of adipocytes modulate multiple physiological functions. Ann Endocrinol (Paris) 1997;58:132-136. (Pubitemid 27259308)
27. Klok MD, Jakobsdottir S, Drent ML The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev 2007;8:21-34. (Pubitemid 44952832)
28. Licinio J, Caglayan S, Ozata M et al. Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci USA 2004;101:4531-4536. (Pubitemid 38437445)
29. Considine RV, Sinha MK, Heiman ML et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-295. (Pubitemid 26033933)
30. Jéquier E. Leptin signaling, adiposity, and energy balance. Ann N Y Acad Sci 2002;967:379-388. (Pubitemid 34721923)
31. Shin MJ, Lee JH, Jang Y et al. Insulin resistance, adipokines, and oxidative stress in nondiabetic, hypercholesterolemic patients: leptin as an 8-epi-prostaglandin F2α determinant. Metab Clin Exp 2006;55: 918-922 (Pubitemid 44183818)
32. Nakanishi S, Yamane K, Kamei N et al. A protective effect of adiponectin against oxidative stress in Japanese Americans: the association between adiponectin or leptin and urinary isoprostane. Metab Clin Exp 2005;54 194-199 (Pubitemid 40174847)
33. Laughlin GA, Barrett-Connor E, May S, Langenberg C Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study Am J Epidemiol 2007;165:164-174 (Pubitemid 46096378)
34. Wannamethee SG, Whincup PH, Lennon L, Sattar N. Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure. Arch Intern Med 2007;167:1510-1517 (Pubitemid 47124181)